Mammalian target of rapamycin (mTOR) controls cell growth and metabolism in response to nutrients, energy, and growth factors. Recent findings have placed the lysosome at the core of mTOR complex 1 (mTORC1) regulation by amino acids. Two parallel pathways, Rag GTPase-Ragulator and Vps34-phospholipase D1 (PLD1), regulate mTOR activation on the lysosome. This review describes the recent advances in understanding amino acid-induced mTOR signaling with a particular focus on the role of mTOR in insulin resistance. The enzyme mTOR plays key roles in the regulation of mammalian cell metabolism and is implicated in nutrient-induced insulin resistance. mTOR (mammalian target of rapamycin) is part of an intricate network of proteins that pass signals from the outside of the cell to intracellular effectors. Mee-Sup Yoon and Cheol Soo Choi from the Gachon University in Korea reviewed the protein complexes mTOR participates in, in particular mTOR complex 1 (mTORC1) and how activation of this complex by amino acids leads to a reduction in insulin signaling. In rats high levels of amino acids have been linked to hyperactive mTORC1 and insulin resistance. A clear picture of all the proteins involved in the regulation of mTOR by amino acids will point to new candidates for therapy of type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Yoon et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Experimental & Molecular Medicine